BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Sanofi flu vaccines licensed and approved for 2022-2023 influenza season

Fluzone® High-Dose Quadrivalent (Influenza Vaccine) and Flublok® Quadrivalent (Influenza Vaccine) are the only two flu vaccines pro...

July 04, 2022 | News

Emerson Strengthens Leadership in Life Sciences Industry with Acquisition of Fluxa

Emerson (NYSE: EMR) today announced it has acquired Fluxa, a leader in the life sciences industry that uses software and modern technology architectures to...

July 01, 2022 | News

Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies an...

June 24, 2022 | News

DTx Leader Sidekick Enters Strategic Collaboration with Lilly to Support Patients with Breast Cancer

International digital therapeutics (DTx) innovator, Sidekick Health (www.sidekickhealth.com), today announces an integrated digital therape...

June 20, 2022 | News

Fluent BioSciences , NanoCellect to improve resolution of single-cell RNA sequencing analysis of rare cell populations

Single-cell researchers are increasingly requiring scalable, flexible and accessible workflow solutions, and the combination of cell sorting on the NanoCel...

June 20, 2022 | News

Merck and Mulliken Center for Theoretical Chemistry Collaborate in Machine Learning Project

Three-year project to focus on molecular representations and computational tools Methods and code developed in the program will be open source Merck,...

June 17, 2022 | News

WuXi ATU and Wugen Announce Manufacturing Partnership to Expedite the Delivery of Novel Cell Cancer Immunotherapies

WuXi Advanced Therapies (WuXi ATU), a global Contract Testing, Development and Manufacturing Organization (CTDMO), and Wugen Inc., a clinical-stage biotech...

June 16, 2022 | News

CerTest Biotec and BD Announce Collaboration on Molecular Diagnostic Test for Monkeypox

CerTest Biotec and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration to develop ...

June 14, 2022 | News

BIO Releases Third-Annual Report on DEI in Biotechnology

The third annual report that examines diversity, equity, and inclusion (DEI) in the biotechnology industry launched today at the 2022 BIO Internationa...

June 14, 2022 | News

FDA Recommends EUA of Novavax COVID-19 Vaccine for People Aged 18 Years and Older

If Emergency Use Authorization is granted by the FDA, the Novavax COVID-19 vaccine would become the first protein-based COVID-19 vaccine available in the...

June 09, 2022 | News

Lonza introduced PyroCell® Monocyte Activation Test - Human Serum System

he PyroCell® Monocyte Activation Test - Human Serum System (PyroCell® MAT HS System) provides more sensitive detection of non-endotoxin pyrogen c...

June 08, 2022 | News

Merck Advances Development Programs in Oncology Focusing on Novel Mechanisms and Pathways

New data from DNA Damage Response (DDR) inhibitor portfolio inform development path for this promising biology Clinical trials in locally advanced head ...

June 06, 2022 | News

Merck Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland

Company to invest in two major Life Science projects over five years Significantly increases membrane manufacturing capacities and enables construction ...

May 23, 2022 | News

CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing

In addition to shortening the vaccination cycle by leveraging the advantages of its single-dose regimen, Convidecia™ can be stably transported and st...

May 20, 2022 | News

Stay Connected